{"id":15159,"date":"2016-07-22T14:43:40","date_gmt":"2016-07-22T21:43:40","guid":{"rendered":"https:\/\/sop.washington.edu\/?page_id=15159"},"modified":"2023-03-30T10:00:41","modified_gmt":"2023-03-30T17:00:41","slug":"targeted-long-acting-combination-antiretroviral-therapy-program","status":"publish","type":"page","link":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/","title":{"rendered":"Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART)"},"content":{"rendered":"<p>Targeted Long Acting HIV Therapy intended to clear virus in tissues and cells<\/p>\n<p>Click <a href=\"http:\/\/depts.washington.edu\/tlcart\/\">here<\/a> to visit\u00a0the TLC-ART website.<\/p>\n<p>The TLC-ART 1 program, founded by Drs. <a href=\"https:\/\/depts.washington.edu\/tlcart\/rodney-ho\/\">Ho<\/a> and <a href=\"https:\/\/depts.washington.edu\/tlcart\/ann-collier\/\">Collier<\/a>, leverages on technical, regulatory, and clinical innovations in the fundamental and biomedical research translation to accelerate discovery into product concepts that will have impacts on infections and cancer or other chronic diseases.<\/p>\n<p>The discovery of the DcNP-enabled drug-combination for current HIV drugs, lopinavir, ritonavir, and tenofovir, assembled as the TLC-ART 101 injectable product also extends plasma and cell drug presence, the TLC-ART 101 is considered long-acting drug product candidate, which is currently a clinical-stage product of the TLC-ART program. Phase 1 clinical testing is funded by NIAID\/NIH.<\/p>\n<p><a href=\"https:\/\/depts.washington.edu\/tlcart\/about\/pipeline\/\">Current<\/a> focuses include infectious diseases (HIV &amp; HBV treatments) and cancers (breast cancer &amp; pancreatic cancer with GT-DcNP). The projects are supported through public-private partnerships and we thank our sponsors and supporters for their support. Major funding was received from the NIH and Unitaid.<\/p>\n<p><a href=\"https:\/\/www.washington.edu\/giving\/make-a-gift\/?code=tlcart&amp;page=make\">Give to the TLC-ART.<\/a><\/p>\n<h3>Contact Information<\/h3>\n<p>UWMC H-Wing rm H115<br \/>\nBox 357610<br \/>\n1959 NE Pacific St.<br \/>\nHealth Sciences Building<br \/>\nSeattle, WA 98195<br \/>\nPhone: (206) 543-8769<br \/>\nFax: (206) 543-3204<\/p>\n<p>or e-mail <a href=\"mailto:tlcart@uw.edu\">tlcart@uw.edu<\/a> directly<\/p>\n<p>Principle Investigator: <a href=\"\/people\/rodney-ho\/\">Dr. Rodney JY Ho, PhD, FAAAS, FAAPS<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Targeted Long Acting HIV Therapy intended to clear virus in tissues and cells Click here to visit\u00a0the TLC-ART website. The TLC-ART 1 program, founded by Drs. Ho and Collier, leverages on technical, regulatory, and clinical&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":19313,"menu_order":51,"comment_status":"closed","ping_status":"closed","template":"templates\/template-pharmaceutics.php","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-15159","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART) - School of Pharmacy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART) - School of Pharmacy\" \/>\n<meta property=\"og:description\" content=\"Targeted Long Acting HIV Therapy intended to clear virus in tissues and cells Click here to visit\u00a0the TLC-ART website. The TLC-ART 1 program, founded by Drs. Ho and Collier, leverages on technical, regulatory, and clinical...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/\" \/>\n<meta property=\"og:site_name\" content=\"School of Pharmacy\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/UWSOP\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-30T17:00:41+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/department-of-pharmaceutics\\\/research\\\/targeted-long-acting-combination-antiretroviral-therapy-program\\\/\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/department-of-pharmaceutics\\\/research\\\/targeted-long-acting-combination-antiretroviral-therapy-program\\\/\",\"name\":\"Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART) - School of Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\"},\"datePublished\":\"2016-07-22T21:43:40+00:00\",\"dateModified\":\"2023-03-30T17:00:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/department-of-pharmaceutics\\\/research\\\/targeted-long-acting-combination-antiretroviral-therapy-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/department-of-pharmaceutics\\\/research\\\/targeted-long-acting-combination-antiretroviral-therapy-program\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/department-of-pharmaceutics\\\/research\\\/targeted-long-acting-combination-antiretroviral-therapy-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Department of Pharmaceutics\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/department-of-pharmaceutics\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Research\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/department-of-pharmaceutics\\\/research\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"name\":\"University of Washington School of Pharmacy\",\"description\":\"University of Washington\",\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"alternateName\":\"UW School of Pharmacy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\",\"name\":\"University of Washington School of Pharmacy\",\"alternateName\":\"UW School of Pharmacy\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"contentUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"width\":526,\"height\":527,\"caption\":\"University of Washington School of Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/UWSOP\",\"https:\\\/\\\/x.com\\\/UW_Pharmacy\",\"https:\\\/\\\/www.instagram.com\\\/uw_pharmacy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UWPharmacySchool\",\"https:\\\/\\\/www.linkedin.com\\\/groups\\\/3820716\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART) - School of Pharmacy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/","og_locale":"en_US","og_type":"article","og_title":"Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART) - School of Pharmacy","og_description":"Targeted Long Acting HIV Therapy intended to clear virus in tissues and cells Click here to visit\u00a0the TLC-ART website. The TLC-ART 1 program, founded by Drs. Ho and Collier, leverages on technical, regulatory, and clinical...","og_url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/","og_site_name":"School of Pharmacy","article_publisher":"http:\/\/www.facebook.com\/UWSOP","article_modified_time":"2023-03-30T17:00:41+00:00","twitter_card":"summary_large_image","twitter_site":"@UW_Pharmacy","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/","name":"Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART) - School of Pharmacy","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website"},"datePublished":"2016-07-22T21:43:40+00:00","dateModified":"2023-03-30T17:00:41+00:00","breadcrumb":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/targeted-long-acting-combination-antiretroviral-therapy-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/"},{"@type":"ListItem","position":2,"name":"Department of Pharmaceutics","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/"},{"@type":"ListItem","position":3,"name":"Research","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/department-of-pharmaceutics\/research\/"},{"@type":"ListItem","position":4,"name":"Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART)"}]},{"@type":"WebSite","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","name":"University of Washington School of Pharmacy","description":"University of Washington","publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"alternateName":"UW School of Pharmacy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization","name":"University of Washington School of Pharmacy","alternateName":"UW School of Pharmacy","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/","url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","contentUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","width":526,"height":527,"caption":"University of Washington School of Pharmacy"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/UWSOP","https:\/\/x.com\/UW_Pharmacy","https:\/\/www.instagram.com\/uw_pharmacy\/","https:\/\/www.youtube.com\/user\/UWPharmacySchool","https:\/\/www.linkedin.com\/groups\/3820716"]}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/15159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/comments?post=15159"}],"version-history":[{"count":0,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/15159\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/19313"}],"wp:attachment":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media?parent=15159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}